Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Surgical Science Sweden AB (publ)    SUS   SE0014428512

SURGICAL SCIENCE SWEDEN AB (PUBL)

(SUS)
  Report
End-of-day quote. End-of-day quote NASDAQ OMX STOCKHOLM - 11/26
85.6 SEK   +0.23%
 SummaryChartsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Nasdaq Omx Stockholm
11/24/2020 11/25/2020 11/26/2020 11/27/2020 11/30/2020 Date
84.9 85.4 85.6 86 86.6 Last
15708 5496 7408 7432 10250 Volume
+0.24% +0.59% +0.23% +0.47% +0.70% Change
Financials
Sales 2020 112 M 13,0 M 13,0 M
Net income 2020 19,0 M 2,22 M 2,22 M
Net cash position 2020 72,9 M 8,51 M 8,51 M
P/E ratio 2020 157x
Yield 2020 -
Sales 2021 168 M 19,6 M 19,6 M
Net income 2021 40,1 M 4,68 M 4,68 M
Net cash position 2021 107 M 12,5 M 12,5 M
P/E ratio 2021 74,4x
Yield 2021 -
Capitalization 2 987 M 349 M 349 M
EV / Sales 2020 26,1x
EV / Sales 2021 17,2x
Nbr of Employees 61
Free-Float 100%
More Financials
Company
Surgical Science Sweden AB is a Sweden-based company, which provides with virtual reality simulators for evidence based laparoscopic and endoscopic training. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range... 
More about the company
Notations Surperformance© of Surgical Science Sweden AB (publ)
Trading Rating : Investor Rating :
More Ratings
All news about SURGICAL SCIENCE SWEDEN AB (PUBL)

- No features available -

More news
News in other languages on SURGICAL SCIENCE SWEDEN AB (PUBL)

- No features available -

More news
Chart SURGICAL SCIENCE SWEDEN AB (PUBL)
Duration : Period :
Surgical Science Sweden AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 108,67 SEK
Last Close Price 86,60 SEK
Spread / Highest target 32,8%
Spread / Average Target 25,5%
Spread / Lowest Target 15,5%
EPS Revisions
Managers
NameTitle
Gisli Hennermark Chief Executive Officer
Roland Bengtsson Chairman
Anna Theresa Ahlberg Chief Financial Officer
Anders Larsson Chief Technology Officer
Jan Bertil Bengtsson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SURGICAL SCIENCE SWEDEN AB (PUBL)0.94%349
VEEVA SYSTEMS INC.96.54%41 696
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED135.56%39 025
OMNICELL, INC.30.41%4 509
SECTRA AB (PUBL)70.08%3 015
B-SOFT CO.,LTD.11.20%2 365